Related Articles
Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer
Serum thymidine kinase 1 reflects the progression of pre-malignant and malignant tumors during therapy
Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity
Serum thymidine kinase 1 is associated with Gleason score of patients with prostate carcinoma